InnoCore actively exploits partnering and collaboration opportunities to complement its expertise and boost the innovation process. We continuously develop new sustained release products in partnership with pharma, biotech, medical device and academic institutions. In addition, InnoCore is always open to discuss in-licensing of new sustained release technologies. Different structures of license and development agreements are possible, depending on the partners’ needs and preferences.
We believe in the power of partnerships, that are based on mutual trust, and recognize the added value of combining erperience, know-how and competences.
Through a network of qualified CMO’s, InnoCore enables support of partners not only during the first feasibility phase, but also during all subsequent product development phases, including the manufacturing and supply of animal trial material for e.g. GLP Toxicity studies, and technology transfer to a cGMP contract manufacturing partner, or the customer, for the manufacturing of clinical trial (GMP). Regulatory support and quality assurance form an integral part of the product development services.
Over the past years, InnoCore has gathered extensive pre-clinical (including animal trials) data, allowing for an efficient and fast product development track. This in turn helps us realize, together with our partners, clinical trials in a timely manner.
Benefits of partering with InnoCore
- Access to several patented drug delivery technologies
- Expertise in sustained release
- Full range of services in formulation, development, and manufacturing
- Life cycle management